(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DESIGNER PHARMZ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

DESIGNER PHARMZ

ST13

US500000098162291

Class

3

Filing

98162291

Registration

7657838

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

01/21/2025

Trademark type

Combined

Nice classes

3

Filing date

09/01/2023

Registration date

01/21/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/21/2025

Last transaction

01/21/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

06/23/2020

First use in commerce

06/23/2020

Drawing code

3

Owner type

03

Owner location

Tarzana, CA

Examiner

BHANOT, KAPIL

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of "DESIGNER" and 'PHARMZ" in all caps in white separated by a stylized white house with a lime leave stem superimposed on purple and orange leafs on a gray floor.

Holders and representatives

Holders

One Vision Enterprises, Inc.

Representatives

Michael J. Moffatt, Esq. FULWIDER PATTON LLP

Technical classification

Nice Classes

Class 3

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

intimate wipes impregnated with a cleaning preparation

Publications

History of USPTO decisions and trademark events.

17 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/21/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/21/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/03/2024

PUBO

PUBLISHED FOR OPPOSITION

12/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/27/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/29/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/29/2024

ALIE

ASSIGNED TO LIE

10/28/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/27/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/30/2024

GNRT

NON-FINAL ACTION E-MAILED

04/30/2024

CNRT

NON-FINAL ACTION WRITTEN

04/30/2024

DOCK

ASSIGNED TO EXAMINER

04/30/2024

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/29/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/28/2023

NWAP

NEW APPLICATION ENTERED

09/05/2023

Continuous trademark protection

Get notified about every new filing that threatens DESIGNER PHARMZ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.